Articles related to Geriatrics

A qualitative study of 169 Colorado adults aged 60 and older found most preferred combination THC-CBD edible products over single-cannabinoid options when seeking relief from pain, sleep, and mood symptoms.

A Swedish national cohort analysis linked bereavement to elevated incident cardiovascular disease risk before and during the COVID-19 pandemic, with the strongest pandemic-period association following partner loss.

Blarcamesine (Anavex 2-73), an investigational once-daily oral autophagy enhancer, showed sustained cognitive, functional, and brain volume benefits through nearly 3 years in a Phase 2b/3 trial and open-label extension presented at AD/PD 2026.

A retrospective ADNI cohort analysis found that omega-3 supplement users showed faster cognitive decline over 5 years than matched non-users, with FDG-PET evidence of reduced brain glucose metabolism.

Online wellness messaging is reframing nicotine pouches, gum, and patches as cognitive enhancers and dementia prevention tools, despite negative results from the larger MIND trial published in December 2025.

Multiple Alzheimer disease biomarkers showed accelerated age-related changes near age 70 in a Mayo Clinic Study of Aging cohort, identifying potential screening and monitoring windows.